Get complete Patent Opposition Report for Medivation Prostate Therapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Medivation Prostate Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3725778Aug 18, 2021Formulations Of Enzalutamide11
EP2739153Aug 22, 2018Treatment Of Breast Cancer2